CEUFAST COURSE

Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19

Contact Hour(s): 1 Contact Hour including 1 Advanced Pharmacology HourAuthor:Sarah Schulze, MSN, APRN, CPNP, PMHS, CLCThis peer-reviewed course is applicable for the following professions: Advanced Practice Registered Nurse (APRN), CCI C...

Course Summary

Contact Hour(s): 

1 Contact Hour including 1 Advanced Pharmacology Hour

Author:

Sarah Schulze, MSN, APRN, CPNP, PMHS, CLC

This peer-reviewed course is applicable for the following professions: 

Advanced Practice Registered Nurse (APRN), CCI Credentialed Specialists, Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Registered Nurse (RN)

Accreditations: 

The American Nurses Credentialing Center (ANCC)

State Approvals:  

 Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353

Course Description:

This course aims to provide nurses with the knowledge base necessary to differentiate MIS-C from other inflammatory conditions and ensure timely identification and management of the illness.

Outcomes:

≥ 92% of participants will know how to identify MIS-C.

Objectives:

After completing this continuing education course, the participant will be able to:

  1. Explain the relationship between the emergence of MIS-C and SARS-CoV-2 incidence.
  2. Identify the risk factors for the development of MIS-C.
  3. Categorize the symptoms of MIS-C by body system.
  4. Compare and contrast MIS-C symptoms from those of the closely related Kawasaki Disease.
  5. Define diagnostic criteria for MIS-C.
  6. Determine the mechanism of action of various treatment modalities for MIS-C.
  7. Formulate potential nursing interventions for care of a child with acute MIS-C.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.